On Monday, April 1, House Judiciary Chairman Jerry Nadler and Antitrust Subcommittee Chairman David Cicilline (Democrat – Rhode Island) sent a letter to Federal Trade Commission (FTC) leadership asking for particulars on how the agency would allocate funding if given more resources to beef up its antitrust enforcement.
The lawmakers pressed the agency on how it would allocate an additional US$50 million to US$100 million, as well as what other resources it might need “to promote competition in digital markets.” The panel leaders also inquired about the possibility of the agency creating a “Bureau of Technology” and what funding and staffing the agency would need to make it run. A number of consumer groups have called for the establishment of a separate agency to potentially handle issues around tech, antitrust and data privacy, but the missive shows Democratic leaders are weighing whether such a unit could be housed in the FTC itself.
“The United States is in the midst of a monopoly crisis. Mounting evidence suggests that market power has increased across the economy, economic concentration has risen, and anticompetitive conduct is undermining the economic opportunity and well-being of the working America,” the letter read.
“With these concerns in mind we would like to learn how the Commission would use additional resources to confront and reverse this trend,” it continued.
Full Content: Cicilline
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas